Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 60 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
ULTRAZONIC from Zandhoven, company number BE0643900747, closed financial year 2025 with a result of € -7,524 after tax. For that financial year ULTRAZONIC recorded a gross margin of € 273,338 and equity of € 974,374. Compared with financial year 2024, the result moved from € 77,857 to € -7,524. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 974,374
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -7,524
▼ still € 77,857 profit in 2024
Profit after tax over the fiscal year.
€ 12,495
▼ 63% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -655,626.
People and assets in 2025
4
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 253,001
▲ 54% vs 2024
€ 63,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,218
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 506,850
▲ 43% vs 2024
Loans from banks and other lenders, long and short.
€ 579,044
▲ 71% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 45,301
▲ 30% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -172,007 | € 640,895 | € 291,512 | € 273,338 | ▼ 6% |
| Profit after taxes | € -438,617 | € 353,515 | € 77,857 | € -7,524 | ▼ € 85,381 |
| Equity | € 256,877 | € 610,392 | € 981,899 | € 974,374 | ▼ 1% |
| Total debts | € 2,587,802 | € 1,108,652 | € 736,065 | € 1,147,521 | ▲ 56% |
| Cash | € 24,052 | € 942 | € 34,006 | € 12,495 | ▼ 63% |
| Retained profit | € -1,079,473 | € -725,958 | € -648,101 | € -655,626 | ▼ € 7,524 |
| Bank debt | € 412,400 | € 592,359 | € 354,500 | € 506,850 | ▲ 43% |
| Balance sheet total | € 2,844,679 | € 1,719,044 | € 1,717,964 | € 2,121,896 | ▲ 24% |
| Employees (FTE) | 3.8 | 3.9 | 3.3 | 4 | ▲ 0.7 |
Key figures of ULTRAZONIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ULTRAZONIC?
What happened at ULTRAZONIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 7,524 (▼ € 85,381 vs 2024). Source: NBB ↗
- Paul Sucaet became a director. NBB
- Serge Wellens became a director. NBB
- Nancy Steenbakkers became a director. NBB
- New establishment in Zandhoven. KBO
- Start of the company according to the CBE. KBO
In short
From € 438,617 loss in 2022 to € 7,524 loss in 2025.
Paid € 3,682 in corporate taxes since 2022.
Best year ever: 2023, with € 353,515 profit.
On average € 68,300 of value added per employee in 2025.
A new publication or filing at ULTRAZONIC? We notify you, reason included.
Follow ULTRAZONICDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Z-PROJECTS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ULTRAZONICBehind ULTRAZONIC are Serge Wellens, Paul Sucaet and Nancy Steenbakkers. The shares are held by Z-PROJECTS (72%).
Directors
According to the 2025 annual accounts
Serge Wellens
Director
since 2017
Paul Sucaet
Director
since 2019
Nancy Steenbakkers
Director
since 2017
Shareholders
72%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Boutersemdreef 26
2240 Zandhoven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
TRANSIP-AS Amsterdam, the Netherlands, NL
Domain
Domain
ultrazonic.com
Registered
2013-01-02
Registrar
Key-Systems GmbH
Expires
2027-01-02
Website info
Features
Security
Details
- Company number
- 0643.900.747
- VAT number
- BE 0643.900.747
- Registered office
- Boutersemdreef 26, 2240 Zandhoven
- Names & denominations
- ULTRAZONIC
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 December 2015
- Peppol
- Active · Active since 17 Dec 2025
- Contact
- ultrazonic.com
- Activities · NACE
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Groothandel in farmaceutische en medische artikelen